Substance binding human IgG Fc receptor IIb

Details for Australian Patent Application No. 2004293184 (hide)

Owner Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.

Inventors Jacob, Uwe; Chiara, Cabrele; Huber, Robert; Wendt, Kerstin; Moroder, Luis; Sondermann, Peter

Agent Davies Collison Cave

Pub. Number AU-B-2004293184

PCT Pub. Number WO2005/051999

Priority 03 027 000.3 26.11.03 EP

Filing date 26 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 16 December 2010

International Classifications

C07K 14/735 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051999 Priority application(s): WO2005/051999

16 December 2010 Application Accepted

  Published as AU-B-2004293184

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293189-Nitroso derivatives of diphenylamine

2004293182-Compositions comprising polypeptides